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Ju-Pin Pan, MD,a Tsai-Mu Cheng, PhD,b Chun-Che Shih, MD, PhD,c Shu-Chiung Chiang, PhD,d
Shiu-Chin Chou, BS,a Simon J. T. Mao, PhD,b and Shiau-Ting Lai, MD,c Taipei and Hsinchu, Taiwan
Objective: Inflammation is associated with the disruption of the aortic media and appears to play a fundamental role in the
progression and development of abdominal aortic aneurysm (AAA). Haptoglobin (Hp) is a genetically determined acute
phase protein, the synthesis of which is increased during inflammation. This study was designed to investigate both
phenotype and plasma levels of Hp in patients with AAA.
Methods: Patients with documented AAA who were admitted for elective open repair operation or endograft stent
implantation, and non-AAA subjects admitted for coronary arteriography, but found to have normal or insignificant
coronary artery disease, were included in the study. Plasma Hp levels were determined using a standard specific
enzyme-linked immunosorbent assay, while Hp phenotype was determined by native polyacrylamide gel electrophoresis.
Total cholesterol, high density lipoprotein, low density lipoprotein, and triglyceride levels were analyzed enzymatically,
and C-reactive protein was analyzed by immunochemistry.
Results: Forty-five patients with AAA and 49 non-AAA subjects were included. The Hp 2-2 phenotype was more
predominant in AAA patients compared with non-AAA subjects, but this difference was not significant (67% vs 47%; P
.141), while plasma Hp concentrations were significantly higher in AAA patients (237  144 vs 163  86 ng/mL; P 
.024). Further analysis revealed that plasma Hp concentrations were significantly higher in AAA patients with the 2-2
phenotype compared with corresponding non-AAA subjects (238  144 vs 163  86 ng/mL;P  .024).
Conclusions: Our findings suggest that plasma Hp concentrations are elevated in patients with AAA, particularly those
with the Hp 2-2 phenotype. (J Vasc Surg 2011;53:1189-94.)
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pAbdominal aortic aneurysm (AAA) is a documented
lethal disorder in older adults, the risk of rupture with
which increases with aneurysm size.1 In normal aortas, the
lamellar structure of media is the thickest layer and is an
orderly array of collagen, elastin, and smooth muscle cells.
Degeneration of this matrix leads to destruction of the
media and adventia, which in turn results in gradual aortic
dilation.2,3 Inflammation is associated with disruption of
the orderly structure of the aortic media and appears to play
a fundamental role in the progression and development of
AAA.4,5
Haptoglobin (Hp) is the major hemoglobin (Hb)-
binding protein in humans and other mammals, and is one
of the few acute phase proteins that exhibits increased
synthesis during inflammation and is conserved in all verte-
brate species studied.6,7 Hp is an extremely potent antiox-
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doi:10.1016/j.jvs.2010.10.122dant that directly inhibits low-density lipoprotein oxida-
ion.8 Structurally, Hp is tetrameric or (---) joined by
isulfide linkages between the two  and  chains. Three
p phenotypes, 1-1, 2-1, and 2-2 share the same two 
hains.9 Functional differences between the Hp pheno-
ypes have been demonstrated; these appear to have impor-
ant biological and clinical consequences.10
Controversy exists with regard to the relationship be-
ween Hp phenotypes and the prevalence of cardiovascular
isease. Findings from the Framingham offspring cohort
uggest that there is decreased prevalence of coronary heart
isease (CHD) in diabetic individuals with allele 2 (Hp 2-1
nd Hp 2-2).11 In contrast, an increased prevalence of
HD was found in nondiabetic subjects with the Hp 2-1
henotype compared with those with the Hp 1-1 pheno-
ype. In another study, it was reported that the risk of
ardiovascular disease in patients with sleep apnea aged
55 years with theHp 2-2 phenotype was 2.32-fold higher
han that in corresponding patients with the 2-1 pheno-
ype.12 Further to this, it has been found that myocardial
nfarction patients with Hp 2-2 have more frequent left
entricular failure than patients with Hp 1-1 and Hp 2-1.13
everal other studies have reported relationships between
he Hp 2-1 phenotype and the occurrence of AAA.14,15
Although Hp phenotypes have been frequently re-
orted to be associated with cardiovascular diseases, human
lasma Hp concentrations, which may be associated with
iseases and of diagnostic significance, have rarely been
eported. This is almost certainly a reflection of the difficult
urification procedures necessary for Hp immunoas-
ay,13,16 although we have previously assayed this protein
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May 20111190 Pan et alin humans and reported that there is significant between-
phenotype variability in plasma Hp levels.17
It would be interesting to know more about the rela-
tionships between plasma Hp levels, Hp phenotype, and
AAA. Hence, the aims of this study were to determine: a)
the association (if any) between Hp phenotype and AAA;
and b) plasma Hp levels in AAA and non-AAA individuals
with different Hp phenotypes.
METHODS
Patients. The study participants were consecutively
enrolled between January 2009 and December 2009 in the
Divisions of Cardiovascular Surgery and Cardiology of
Taipei Veterans General Hospital. The cohort consisted of
45 patients with AAA and 49 non-AAA subjects.
Elective open repair operation or endograft stent im-
plantation was performed whenever informed consent was
obtained after consensus indications of surgery were ex-
plained to the patients with AAA. During the same period,
patients with positive thallium-201 myocardial perfusion
scans admitted with suspected coronary artery disease but
showing normal or insignificant coronary artery disease
(40% luminal stenosis), normal ventricular diameter (as
determined by both coronary arteriography and left ven-
triculography), and normal abdominal aorta diameter (as
determined by aortographic examination) were catego-
rized as non-AAA. Patients with acute or chronic infectious
diseases and malignancy were excluded from the study.
Analysis of lipid profiles. Blood samples were ob-
tained (before surgical intervention) from all patients fol-
lowing overnight fasting (12 hours) and mixed with 0.1%
ethylenediamine tetraacetic acid. Total cholesterol, high
density lipoprotein, low density lipoprotein, and triglycer-
ide levels were analyzed enzymatically using commercial
reagents (CHOP-PAP Method; Merck Scientific Corpora-
tion, Germany). ApoAI concentration was determined by
high sensitivity enzyme-linked immunosorbent assay
(AlerCHEK, Inc, Portland, Me).
Measurement of human C-reactive protein (CRP)
plasma levels. The IMMAGE Immunochemistry Systems
CRPH reagent (Beckman Coulter, Inc, Fullerton, Calif),
based on the highly sensitive Near Infrared Particle Immu-
noassay rate methodology, was used to measure CRP. In
this assay, an anti-CRP coated particle binds to CRP in the
patient sample, resulting in the formation of insoluble
aggregates causing turbidity. The rate of aggregate forma-
tion is directly proportional to the concentration of CRP in
the sample.18
Hp phenotyping. Hb was isolated from lysed red
blood cells. Hp phenotyping was conducted by native
polyacrylamide gel electrophoresis with Hb-supplemented
plasma. This assay has been described in detail in our
previous publication.17
Hp purification. Hp purification was performed us-
ing Ab-affinity chromatography. The affinity column (with
a 10 mL bed volume at room temperature) was washed
with 50 mL of phosphate buffered saline. The bound
materials were further washed with 50 mL of 0.02 M Ahosphate buffer containing 0.2 M NaCl (pH 7.4), and
hen eluted with 50 mL of a freshly prepared 0.15 M NaCl
olution (pH 11). Five milliliters of each fraction was
ollected in a tube containing 0.25 mL of 1M Tris-HCl
uffer (pH 6.8) to facilitate neutralization of solution.
Pooled fractions containing Hp were then concen-
rated to a final volume of 1 mL using Centricon tubes
Millipore, Cork, Ireland) and filtered through a 0.45-m
embrane. Finally, the protein was run on a gel-filtration
PLC Superose-12 column (1 30 cm; Pharmacia, Upp-
ala, Sweden). The homogeneity of each isolated Hp type
as 95% as determined by sodium dodecyl sulfate poly-
crylamide gel electrophoresis.
Lyophilized Hp was stored at 80°C until analysis.
Preparation of anti-Hp monoclonal antibodies. Six
onoclonal antibodies (8B1-3A, W1-11G, 2-3H, G2D-
G, 12B-1, and 4A2-4H) against human Hp were pro-
uced and characterized as previously described.17 Mono-
lonal antibody 8B1-3A, which possesses the highest
inding affinity for Hp, was selected for preparation of the
ffinity column. Briefly, 120 mL of cultured medium from
he 8B1-3A hybridoma was precipitated in 50% saturated
mmonium sulfate. The precipitate was dissolved in 12 mL
f phosphate buffered saline (PBS) containing 0.02 M
hosphate and 0.15M NaCl (pH 7.4). The solution was
hen dialyzed exhaustively in PBS to remove the remaining
mmonium sulfate. This was followed by dialysis in cou-
ling buffer containing 0.1M NaHCO3 and 0.6M NaCl,
pH 8.3). All monoclonal antibody binding epitopes were
irected against the -chain.
Measurement of human-free Hp plasma levels.
uman-free Hp plasma levels were measured using a
henotype-matched standard sandwich enzyme-linked
mmunosorbent assay, which has been comprehensively
escribed in a previous publication.17
Statistical analysis. Normal distributed continuous
ariables are presented as the mean  standard deviation.
bnormally distributed continuous variables are presented
s the median (interquartile range). Categorical variables
re presented as the number in each category and the
ercentage. Data were compared between groups by inde-
endent samples t test (normally distributed continuous
ariables), Mann-Whitney U test (abnormally distributed
ontinuous variables) and	2 or Fisher’s exact test (categor-
cal variables). Two-way analysis of variance was performed
o examine the relationship between age and Hp concen-
ration with regard to AAA grouping (AAA or non-AAA).
ubsequent analysis of covariance was performed due to the
ack of a significant interaction effect. All analyses were
erformed using SAS statistical software (version 9.1.3;
AS Inc, Cary, NC). All tests were two-sided, with differ-
nces being considered significant when P  .05.
ESULTS
A total of 94 subjects were recruited during the study
eriod. Table I summarizes the characteristics of the 94
ubjects with respect to AAA grouping (ie, AAA or non-
AA). There were no between-group differences in terms
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Volume 53, Number 5 Pan et al 1191of age, gender distribution, body mass index, smoking or
drinking habits, diabetes history, Hp phenotype distribu-
tion, or any biochemical measure. Patients with AAA had
significantly higher concentrations of Hp than their non-
AAA counterparts (P 
 .017), and a significantly higher
percentage of these patients also suffered from hyperten-
sion (P .001). The concentration of CRP was marginally
higher (P 
 .049) in AAA patients.
Table II summarizes plasma Hp concentrations with
respect to phenotype and AAA status. Plasma Hp concen-
trations for the 2-2 phenotype were significantly higher in
patients with AAA compared with those who did not have
AAA (P 
 .024). Plasma concentrations of Hp in pheno-
type 1-1 and 2-1 patients were somewhat higher in those
with AAA, but this trend did not reach statistical signifi-
cance.
The effect of hypertension on the association between
AAA and plasmaHp concentration is shown in Table III. In
Table I. Summary of demographic characteristics, laborat
this study
Non
Age (years)a
Male genderc
Body mass index (kg/m2)b
Total cholesterol (mg/dL)a 1
Triglyceride (mg/dL)a 1
High density lipoprotein cholesterol (mg/dL)a
Low density lipoprotein cholesterol (mg/dL)b
Hp concentration (ng/mL)b
C-reactive protein concentration (mg/dL)b 0
Smokingc
Drinkingc
Diabetesd
Hypertensionc
Hp phenotyped
1-1
2-1
2-2
AAA, Abdominal aortic aneurysm; Hp, haptoglobin.
Continuous variables are presented as median (interquartile range) or mean
eP values were determined by Mann-Whitney U test,a independent samples
fIndicates a statistically significant between groups difference (P  .05).
Table II. Plasma Hp concentrations stratified with
respect to Hp phenotype and whether the patient did or
did not have AAA
Plasma Hp concentration (ng/mL)
Hp phenotype Non-AAA (n 
 49) AAA (n 
 45) P valuea
1-1 105  60 276  143 .089
2-1 226  123 288  193 .256
2-2 163  86 238  144 .024b
AAA, Abdominal aortic aneurysm; Hp, haptoglobin.
aData are presented as mean  standard deviation and were compared by
independent samples t tests.
bIndicates a statistically significant between groups difference (P  .05).patients without hypertension, plasma Hp concentration pas significantly higher in the AAA group (P 
 .019), but
n patients with hypertension, the plasmaHp concentration
as similar in both AAA and non-AAA groups. Hyperten-
ion was not associated with Hp levels in the absence of
AA (P 
 .069).
As age has been reported to be related to AAA,19 the
ffect of age on plasma Hp levels in the 53 patients with the
-2 phenotype was examined. There was no significant
nteraction between age and the occurrence of AAA (ie, the
orrelation between these variables was similar for both the
AA and non-AAA groups [data not shown]). Subsequent
nalysis of covariance revealed that AAA status was the only
ignificant factor affecting Hp concentration. For the 2-2
henotype, plasma Hp concentrations were significantly
igher in patients with AAA compared with subjects who
id not have AAA (P 
 .031). Age was not significantly
ssociated with plasma Hp level (P 
 .380; Fig).
In the study cohort, aspirin was prescribed in 13 AAA
atients and eight non-AAA patients. In the total patient
ata, and Hp phenotypes for the 94 subjects included in
(n 
 49) AAA (n 
 45) P valuee
2, 79) 76 (73, 80) .404
4) 39 (87) .684
 3.4 23.7  2.9 .106
 32.9 178  45 .771
2, 163) 114 (90, 145) .389
0, 50) 40 (34, 48) .585
 34 110  38 .942
 108 254  158 .017f
 1.086 1.107  2.073 .0496
0) 31 (69) .064
4) 15 (33) .943
) 7 (16) .084
9) 32 (71) .001f
.141
) 2 (4)
5) 13 (29)
7) 30 (67)
ndard deviation; categorical are presented as number (%).
b 	2 test,c or Fisher’s exact test.d
able III. Plasma Hp concentrations stratified with
espect to hypertension and whether the patient did or
id not have abdominal aortic aneurism
Plasma Hp concentration (ng/mL)
ypertension Non-AAA (n 
 49) AAA (n 
 45) P valuea
o 182  117 333  195 .019b
es 196  85 220  128 .517
AA, Abdominal aortic aneurysm; Hp, haptoglobin.
Data are presented as mean  standard deviation and were compared by
ndependent samples t tests.
Indicates a statistically significant between groups difference (P  .05).ory d
-AAA
74 (7
41 (8
24.8
80.8
03 (7
37 (3
111
186
.476
24 (5
16 (3
2 (4
14 (2
4 (8
22 (4
23 (4
 staopulation, no statistically significant difference in Hp con-
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May 20111192 Pan et alcentration was found between patients taking aspirin and
those not taking aspirin (P 
 .193). When patients were
subgrouped into AAA and control (non-AAA) patients, no
difference in Hp concentration was found between control
patients taking aspirin and those not taking this drug (P 

.960). However, AAA patients taking aspirin had lower Hp
concentrations than those not taking aspirin (P 
 .006).
DISCUSSION
In this study, we examined the relationships between
plasma Hp levels and Hp phenotype in patients who did
and did not have AAA. While there were some trends
toward differences in phenotypic distribution between the
AAA and non-AAA individuals, these did not reach statis-
tical significance. Of note, however, plasma Hp levels were
significantly higher in 2-2 phenotype patients with AAA
compared with their non-AAA counterparts with the same
Hp phenotype. This effect was independent of age. Also, in
AAA patients, Hp levels were significantly higher in patients
not taking aspirin than in those taking this anti-inflamma-
tory drug. This result indirectly shows that the increase in
Hp concentration is closely related to the inflammatory
response that leads to AAA pathology.
Hypertension has been documented as a risk factor like
other clinical risk factors, including smoking, advanced age,
male gender, chronic obstructive pulmonary disease, and
family history that predisposes individuals to degenerative
diseases in the arterial wall.20 In our study, a significant
interaction between hypertension and AAA was found, but
Fig. Scatterplot showing age and plasma haptoglobin (Hp) con-
centration for the 53 2-2 phenotype study participants (abdominal
aortic aneurysm [AAA] and non-AAA). The solid line is the fitted
line for the AAA group, while the dotted line is the fitted line for the
non-AAA group. Two-way analysis of variance revealed that there
was no interaction between age and group (AAA and non-AAA).
Hence the interaction term was removed, and analysis of covari-
ance was performed. The result of analysis of covariance revealed a
significant effect of AAA (P 
 .031) but non-significant effect of
age (P 
 .380).hypertension gave no add-on effect to Hp concentration Hor AAA diagnosis. Therefore, it seems that Hp is an
ndependent risk factor for AAA.
In humans there exist two classes of alleles for Hp,
esignated one and two. The Hp polymorphism is a com-
on polymorphism. A geographic ethnic difference in Hp
henotypes has been reported between Western and Asian
opulations. In Western populations, it has been reported
hat 16% of individuals have the 1-1 phenotype, 36% the
-2 and 48% the 2-1.21 In contrast, the frequency of the 1
o 1 phenotype has been found to be lower in Asian
opulations, while the frequency of 2 to 2 is higher.1,10,22
he findings from the current study regarding phenotype
istribution are in agreement with those previously re-
orted.
In the present study, there was an increased (but non-
ignificant) tendency for individuals with AAA to have the
-2 phenotype. This finding contrasts with that reported by
orrgard and colleagues, who found that there was an
ncreased frequency of the 2-1 phenotype in Northern
wedish individuals with AAA.14 The reason for this incon-
istency is unclear, but may be related to ethnicity. It also
ust be acknowledged that a larger number of patients
hould be studied to confirm our findings.
Other studies have reported increased incidences of
isease in individuals with the Hp 2-2 phenotype. Asleh et
l reported that diabetic individuals homozygous for the
p 2 allele (Hp 2-2) had a five-fold greater risk of cardio-
ascular disease compared with diabetic individuals ho-
ozygous for theHp 1 allele (Hp 1-1).23 These researchers
lso found that hemoglobin within plaque derived from
icrovascular hemorrhage was cleared more slowly from
laques associated with the Hp 2-2 phenotype as compared
ith Hp 1-1 plaques.24 This suggests that the Hp 2-2
henotype is associated with an increased risk of atheroscle-
otic cardiovascular disease. In a recently published study of
iabetic transgenic mice,25 it was found that the Hp 2-2
henotype was associated with increased mortality and
ore severe cardiac remodeling 30 days after myocardial
nfarction. In addition, Hp 2-2 has been associated with
efractory hypertension,26 is a predictor of diabetic ne-
hropathy,27 is associated with a higher risk of mortality in
uberculosis,28 and a lower hepatitis B level29 than other
henotypes.
The Hp 2-2 phenotype differs structurally from the
ther two phenotypes in that these phenotypes are either
imers (Hp 1-1) or form linear polymers (Hp 2-1) while
he 2-2 phenotype polymerizes into rosettes of varying
omplexity. Scavenging of Hb by endocytosis of Hb -Hp
omplexes has been found to occur via the CD163 recep-
or.30 Hp 1-Hb complexes stimulate anti-inflammatory
acrophages, while Hp 2-Hb complexes do not. Strauss
nd Levy reported that casein kinase II activity was in-
reased following the binding of Hp 1-1 Hb to CD163.31
educed clearance of the macrophage-Hp-Hb complex,
avoring iron deposition, oxidative stress, and active mac-
ophage accumulation was found in individuals with the
p 2-2 phenotype.32 Impaired Hb clearance capacity has
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rupture propensity.33
Increased matrix metalloproteinases (MMP)-9 and
MMP-2 activity is associated with destruction of the elastic
laminae of arteries and aneurysm formation in humans.34
Complexes of MMP-9 and Hp have been detected in sera
of cows with acute inflammation, but not in clinically
normal cows or cows with chronic disease.35 The interac-
tion between Hp and MMP in aneurysm development has
not been fully investigated. A functional study performed
by de Kleijn et al revealed that Hp inhibits the activity of
MMP-2 by 50% and MMP-9 by 30% in cultured arterial
smooth muscle culture cells, but increases the production
of gelatin in arterial smooth muscle cells in Hp knockout
mice.36 These findings suggest that Hp may play a role in
the regulation of the arterial restructuring.
All of the above observations suggest that individuals
with specific Hp phenotypes may respond differently to
biological insults such as inflammation and vessel wall
degeneration. The synthesis of Hp may reflect a regulatory
response to these pathologic processes. In the present
study, the finding that plasma Hp concentrations were
significantly higher in patients with AAA of the 2-2 pheno-
type compared to corresponding non-AAA individuals is of
interest and agrees with our previous findings demonstrat-
ing that significant between-phenotype variability in plasma
Hp levels occurs.17 However, in this case-control observa-
tional study, the study cohort was recruited from a hospital-
based population, was relatively small in size (with a narrow
age range), and although the two study arms had similar
demographics, some unknown bias might have occurred
because the patients were not randomly selected. If the
results of this study are confirmed and extended by a further
larger scale, more stringently designed study, Hp pheno-
type and concentration may be potential biomarkers of
abdominal aortic aneurysm development that can be used
clinically in association with other biomarkers.
The authors wish to express their gratitude to Ms
Shiu-Ching Chou for her unfailing support and assistance
in performing laboratory analyses.
AUTHOR CONTRIBUTIONS
Conception and design: J-PP, C-CS, SM, S-TL
Analysis and interpretation: J-PP, T-MC
Data collection: J-PP, S-CCho, S-TL
Writing the article: J-PP
Critical revision of the article: J-PP, SM
Final approval of the article: J-PP
Statistical analysis: J-PP, S-CChi
Obtained funding: J-PP, C-CS, S-TL
Overall responsibility: J-PP, T-MC, C-CS, S-CChi,
S-CCho, SM, S-TL
REFERENCES1. Liang CC, Qi ZB, Ying QL, Wang LF. Types and subtypes of hapto-
globin in the Chinese population. Hum Genet 1983;63:175-7.2. Gandhi RH, Irizarry E, Cantor JO, Keller S, Nackman GB, Halpern VJ,
et al. Analysis of elastin cross-linking and the connective tissue matrix of
abdominal aortic aneurysms. Surgery 1994;115:617-20.
3. White JV, Haas K, Phillips S, Comerota AJ. Adventitial elastolysis is a
primary event in aneurysm formation. J Vasc Surg 1993;17:371-80.
4. Gertz SD, Kurgan A, Eisenberg D. Aneurysm of the rabbit common
carotid artery induced by periarterial application of calcium chloride in
vivo. J Clin Invest 1988;81:649-56.
5. Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB.
Elastase-induced experimental aneurysms in rats. Circulation 1990;82:
973-81.
6. Roguin A, Hochberg I, Nikolsky E, Markiewicz W, Meisel SR, Hir J,
et al. Haptoglobin phenotype as a predictor of restenosis after
percutaneous transluminal coronary angioplasty. Am J Cardiol 2001;
87:330-2:A9.
7. Morimatsu M, Syuto B, Shimada N, Fujinaga T, Yamamoto S, Saito M,
et al. Isolation and characterization of bovine haptoglobin from acute
phase sera. J Biol Chem 1991;266:11833-7.
8. Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJ. Antioxidant role of
human haptoglobin. Proteomics 2004;4:2221-8.
9. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis
RM, et al. Structure-function analysis of the antioxidant properties of
haptoglobin. Blood 2001;98:3693-8.
0. Langlois MR, Delanghe JR. Biological and clinical significance of
haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-
1600.
1. Levy AP, Larson MG, Corey D, Lotan R, Vita JA, Benjamin EJ.
Haptoglobin phenotype and prevalent coronary heart disease in the
Framingham offspring cohort. Atherosclerosis 2004;172:361-5.
2. Lavie L, Lotan R, Hochberg I, Herer P, Lavie P, Levy AP. Haptoglobin
polymorphism is a risk factor for cardiovascular disease in patients with
obstructive sleep apnea syndrome. Sleep 2003;26:592-5.
3. Liau CY, Chang TM, Pan JP, ChenWL,Mao SJ. Purification of human
plasma haptoglobin by hemoglobin-affinity column chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci 2003;790:209-16.
4. Norrgard O, Frohlander N, Beckman G, Angqvist KA. Association
between haptoglobin groups and aortic abdominal aneurysms. Hum
Hered 1984;34:166-9.
5. Wiernicki I, Millo B, Ciechanowski K, Cnotliwy M, Gutowski P, Sobus
A, et al. The pathogenesis of abdominal aortic aneurysm and polymor-
phism of haptoglobin and inflammatory factor. Wiad Lek 1999;52:
581-6.
6. Tseng CF, Huang HY, Yang YT, Mao SJ. Purification of human
haptoglobin 1-1, 2-1, and 2-2 using monoclonal antibody affinity
chromatography. Protein Expr Purif 2004;33:265-73.
7. Cheng TM, Pan JP, Lai ST, Kao LP, Lin HH, Mao SJ. Immunochemi-
cal property of human haptoglobin phenotypes: determination of
plasma haptoglobin using type-matched standards. Clin Biochem 2007;
40:1045-56.
8. U.S. Department of Health and Human Services, Food and Drug
Administration, Center for Devices and Radiological Health, Office of
In Vitro Diagnostic Devices. Review criteria for assessment of C-
reactive protein (CRP), high sensitivity C-reactive protein (hsCRP) and
cardiac C-reactive protein (cCRP) assays. Available at: http://www.
fda.gov/cdrh/oivd/guidance/1246.html. Accessed October 3, 2010.
9. Morris GE, Hubbard CS, Quick CR. An abdominal aortic aneurysm
screening programme for all males over the age of 50 years. Eur J Vasc
Surg 1994;8:156-60.
0. Lambert ME, Baguley P, Charlesworth D. Ruptures abdominal aortic
aneurysms. J Cardiovasc Surg (Torino) 1986;27:256-61.
1. Bowman BH, Haptoglobin KA. The evolutionary product of duplica-
tion, unequal crossing over, and point mutation. Adv Hum Genet
1982;12:189-4.
2. Xu JJ, Cui MY, Li SZ, Chen LZ, Du RF, Goedde HW, et al. Polymor-
phisms of Pi, HP, ADA, and AK in Mongolian, Korean, and Zhuang
populations of China. Ann Hum Biol 1986;13:245-51.
3. Asleh R, Marsh A, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, et al.
Genetically determined heterogeneity in hemoglobin scavenging and
susceptibility to diabetic cardiovascular disease. Circ Res 2003;92:
1193-200.
33
3
3
3
JOURNAL OF VASCULAR SURGERY
May 20111194 Pan et al24. Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP. Hapto-
globin genotype- and diabetes-dependent differences in iron-mediated
oxidative stress in vitro and in vivo. Circ Res 2005;96:435-41.
25. Asaf R, Blum S, Roguin A, Kalet-Litman S, Kheir J, Frisch A, et al.
Haptoglobin genotype is a determinant of survival and cardiac remodeling
after myocardial infarction in diabetic mice. Cardiovasc Diabetol 2009;8:29.
26. Delanghe J, Duprez D, De Buyzere M, Bergez B, Claeys L, Leroux-
Roels G, et al. Refractory hypertension is associated with the haptoglo-
bin 2-2 phenotype. J Cardiovasc Risk 1995;2:131-6.
27. Levy AP, Roguin A, Marsh S, Nakhoul F, Herer P, Hochberg I, et al.
Haptoglobin phenotype and vascular complications in diabetes. N Engl
J Med 2000;343:369-70.
28. Kasvosve I, Gomo ZA, Myundura E, Moyo VM, Saungweme T,
KhumaloH, et al. Haptoglobin polymorphism andmortality in patients
with tuberculosis. Int J Tuberc Ling Dis 2000;4:771-3.
29. Louagie H, Delanghe J, Desombere I, De Buyzere M, Hauser P,
Leroux-Roels G. Haptoglobin polymorphism and the immune re-
sponse after hepatitis B vaccination. Vaccine 1993;11:1188-90.
30. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law
SK, et al. Identification of the haemoglobin scavenger receptor. Nature
2001;409:198-201.
31. Strauss M, Levy AP. Regulation of CD163 associated casein kinase II
activity is haptoglobin genotype dependent. Mol Cell Biochem 2008;
317:131-5. S2. Moreno PR, Purushothaman KR, PurushothamanM,Muntner P, Levy
NS, Fuster V, et al. Haptoglobin genotype is a major determinant of the
amount of iron in the human atherosclerotic plaque. J Am Coll Cardiol
2008;52:1049-51.
3. Levy AP, Purushothaman KR, Levy NS, PurushothamanM, Strauss M,
Asleh R, et al. Downregulation of the hemoglobin scavenger receptor in
individuals with diabetes and the Hp 2-2 genotype: implications for the
response to intraplaque hemorrhage and plaque vulnerability. Circ Res
2007;101:106-10.
4. Longo GM, XiongW, Greiner TC, Zhao Y, Fiotti N, Baxter BT.Matrix
metalloproteinases 2 and 9 work in concert to produce aortic aneu-
rysms. J Clin Invest 2002;110:625-32.
5. Bannikov GA, Mattoon JS, Abrahamsen EJ, Premanandan C, Green-
Church KB, Marsh AE, et al. Biochemical and enzymatic characteriza-
tion of purified covalent complexes of matrix metalloproteinase-9 and
haptoglobin released by bovine granulocytes in vitro. Am J Vet Res
2007;68:995-1004.
6. de Kleijn DP, Smeets MB, Kemmeren PP, Lim SK, van Middelaar BJ,
Velema E, et al. Acute-phase protein haptoglobin is a cell migration
factor involved in arterial restructuring. FASEB J 2002;16:1123-5.ubmitted Apr 28, 2010; accepted Oct 27, 2010.
